| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.9M | — | +1.6% |
| Cost of Revenue | $2.7M | — | +8.5% |
| Gross Profit | $6.1M | — | -1.3% |
| R&D Expense | $1.0M | — | -38.4% |
| SG&A Expense | $8.1M | — | -3.4% |
| Operating Income | -$3.0M | — | +21.7% |
| Income Tax | $0 | — | — |
| Net Income | -$5.1M | — | -246.9% |
| EPS (Basic) | -$0.08 | — | -300.0% |
| EPS (Diluted) | -$0.08 | — | -300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.8M | -23.0% | -58.5% |
| Accounts Receivable | $7.2M | -5.3% | -6.8% |
| Inventory | $4.5M | -15.1% | +48.5% |
| Current Assets | $17.8M | -13.9% | -30.1% |
| Total Assets | $40.6M | -8.2% | -20.1% |
| Current Liabilities | $16.3M | +67.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.2M | — | +66.5% |
| Capital Expenditures | $11K | — | +418.6% |
| Investing Cash Flow | -$46K | — | +2.6% |
| Financing Cash Flow | $6.8M | — | -0.0% |
| Free Cash Flow | -$1.2M | — | +66.2% |
| +67.4% |
| Long-term Debt | $17.0M | +1.8% | +19.5% |
| Total Liabilities | $38.4M | +0.2% | +5.9% |
| Stockholders' Equity | $2.2M | -62.8% | -84.9% |